A study by Tamayo-Velasco et al. (2021) explains HGF as a biomarker which substantially related to severe/critical COVID-19 patients at hospital admission and is hence an excellent indicator of poor prognosis and also used as a mortality biomarker [62]. Here, HGF is linked to COVID-19.